These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 21737020)

  • 1. Mortality risk of Fidelis management.
    Faddis MN
    J Am Coll Cardiol; 2011 Jul; 58(3):284-5. PubMed ID: 21737020
    [No Abstract]   [Full Text] [Related]  

  • 2. Transvenous implantable cardioverter-defibrillator leads: the weakest link.
    Maisel WH
    Circulation; 2007 May; 115(19):2461-3. PubMed ID: 17502585
    [No Abstract]   [Full Text] [Related]  

  • 3. A fatal complication of ICD therapy due to lead failure.
    Theuns DA; Szili-Torok T; Jordaens LJ
    J Cardiovasc Electrophysiol; 2008 Jul; 19(7):E48. PubMed ID: 18554196
    [No Abstract]   [Full Text] [Related]  

  • 4. Impact of implanted recalled sprint Fidelis lead on patient mortality.
    Morrison TB; Friedman PA; Kallinen LM; Hodge DO; Crusan D; Kumar K; Hayes DL; Rea RF; Hauser RG
    J Am Coll Cardiol; 2011 Jul; 58(3):278-83. PubMed ID: 21737019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relationship between Sprint Fidelis leads and patient mortality.
    Maytin M; Epstein LM
    J Am Coll Cardiol; 2012 Jan; 59(2):193-4. PubMed ID: 22222084
    [No Abstract]   [Full Text] [Related]  

  • 6. [The "clinical cost" of implantable cardioverter-defibrillators in the primary prevention of sudden cardiac death is underestimated].
    Disertori M
    G Ital Cardiol (Rome); 2011 May; 12(5):374-8; discussion 378. PubMed ID: 21593957
    [No Abstract]   [Full Text] [Related]  

  • 7. Sudden and Fatal Malfunction of a Durata Defibrillator Lead due to External Insulation Failure.
    Shah AD; Hirsh DS; Langberg JJ
    Pacing Clin Electrophysiol; 2016 Jan; 39(1):101-4. PubMed ID: 26293817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computed tomography's crucial role in averting a life-threatening complication of lead extraction.
    Srivatsa UN; Dinh H; Stark S
    Heart Rhythm; 2013 Feb; 10(2):308-9. PubMed ID: 21952005
    [No Abstract]   [Full Text] [Related]  

  • 9. Inappropriate implantable cardioverter defibrillator shocks in fractured Sprint Fidelis leads associated with 'appropriate' interrogation.
    Farwell D; Redpath C; Birnie D; Gollob M; Lemery R; Posan E; Green M
    Europace; 2008 Jun; 10(6):726-8. PubMed ID: 18456645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lead system causing twiddler's syndrome in patients with an implantable cardioverter-defibrillator.
    Bracke F; van Gelder B; Dijkman B; Meijer A
    J Thorac Cardiovasc Surg; 2005 Jan; 129(1):231-2. PubMed ID: 15632856
    [No Abstract]   [Full Text] [Related]  

  • 11. Optimal programming of implantable cardiac-defibrillators.
    Madhavan M; Friedman PA
    Circulation; 2013 Aug; 128(6):659-72. PubMed ID: 23918187
    [No Abstract]   [Full Text] [Related]  

  • 12. Annual rate of transvenous defibrillation lead defects in implantable cardioverter-defibrillators over a period of >10 years.
    Kleemann T; Becker T; Doenges K; Vater M; Senges J; Schneider S; Saggau W; Weisse U; Seidl K
    Circulation; 2007 May; 115(19):2474-80. PubMed ID: 17470696
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complications with laser-lead extraction.
    Garmon EH; Johnston WE
    J Cardiothorac Vasc Anesth; 2010 Dec; 24(6):974-6. PubMed ID: 20116289
    [No Abstract]   [Full Text] [Related]  

  • 14. Malfunctions in implantable cardiac devices: putting the risk in perspective.
    Burkhardt JD; Wilkoff BL
    Cleve Clin J Med; 2005 Sep; 72(9):736, 738, 742 passim. PubMed ID: 16193821
    [No Abstract]   [Full Text] [Related]  

  • 15. Excimer laser assisted implantable cardioverter defibrillator lead extraction: An alternative treatment to the surgery?
    Güngör H; Duygu H; Yildiz BS; Gül I; Zoghi M; Akin M
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):340-1. PubMed ID: 19666438
    [No Abstract]   [Full Text] [Related]  

  • 16. When life-saving devices terminate life.
    Catanchin A; Anderson L; Jones S; Ward D
    J Cardiovasc Electrophysiol; 2008 Mar; 19(3):316-8. PubMed ID: 18266677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longevity of Sprint Fidelis implantable cardioverter-defibrillator leads and risk factors for failure: implications for patient management.
    Hauser RG; Maisel WH; Friedman PA; Kallinen LM; Mugglin AS; Kumar K; Hodge DO; Morrison TB; Hayes DL
    Circulation; 2011 Feb; 123(4):358-63. PubMed ID: 21242478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recall actions for implantable defibrillators -- how do you counsel your defibrillator patients now?].
    Lüderitz B
    MMW Fortschr Med; 2005 Aug; 147(33-34):8-9. PubMed ID: 16138625
    [No Abstract]   [Full Text] [Related]  

  • 19. Importance of complete system removal of infected cardioverter-defibrillators.
    Mull DH; Wait MA; Page RL; Jessen ME
    Ann Thorac Surg; 1995 Sep; 60(3):704-6. PubMed ID: 7677511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lead fracture and free-wall perforation in a patient with an implantable cardioverter-defibrillator.
    Kwon O; Kang SH; Park HW; Choi SW; Kim SH; Kim KH; Jin ES; Nam GB
    Pacing Clin Electrophysiol; 2012 Jun; 35(6):e167-9. PubMed ID: 21070262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.